Integrated Core Strategies (US) LLC 13D/13G Filings for Freeline Therapeutics Holdings plc (FRLN)

Integrated Core Strategies (US) LLC 13D and 13G filings for Freeline Therapeutics Holdings plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-12
4:24 pm
Sale
2023-12-3113GFreeline Therapeutics Holdings plc
FRLN
Integrated Core Strategies (US) LLC0
0.000%
-5,555,085decrease
(Position Closed)
Filing
2023-07-17
4:50 pm
Purchase
2023-07-1213GFreeline Therapeutics Holdings plc
FRLN
Integrated Core Strategies (US) LLC5,555,085
8.500%
5,555,085increase
(New Position)
Filing